Results of the randomised phase II NCRI arctic (attenuated dose rituximab with chemotherapy in CLL) trial of low dose rituximab in previously untreated CLL
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article in Journal/Newspaper |
Language: | unknown |
Published: |
2016
|
Subjects: | |
Online Access: | https://ora.ox.ac.uk/objects/uuid:2ab60540-bb4d-44e0-830b-8a1d33e68e6c |
Description not available. |